Respiratory

Hikma Ventures is the strategic venture capital arm of Hikma Pharmaceuticals, investing in innovative digital health and life sciences companies worldwide. They invest in disruptive technologies and meaningful companies with a diverse leadership team. Their investment mandate is broad, focusing on areas where they see strategic advantages for both Hikma and their portfolio companies.

Jeito Capital is a leading global investment company focused on biopharmaceuticals. They finance and accelerate cutting-edge medical innovation with a patient benefit approach, supporting entrepreneurs through significant capital contributions and expert guidance.